Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Adapters >> Transmembrane
Anti-TAP1 antibody
See all TAP1 products (8) ...
Rabbit polyclonal to TAP1
This antibody detects an ~70 kDa protein, corresponding to the apparent molecular mass of Transporter Associated with Antigen Processing 1 (TAP1) on SDS-PAGE immunoblots. The immunogen sequence used to generate this antibody is based on the sequence of ATP-binding cassette sub-family B member 2.
WB, IP, ICCmore details
Reacts with
Rat, Human
Synthetic peptide: CYWAMVQAPADAPE, corresponding to amino acids 735-748 of Human TAP1 (member 2).
CYWAMVQAPA DAPE
HeLa cell lysate.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: None
Constituents: Whole Serum
Whole antiserum
Polyclonal
IgG
Our Abpromise guarantee covers the use of ab13516 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/4000Detects a band of approximately 70 kDa.
IP: 1/100
ICC: Use at an assay dependent dilution.
Involved in the transport of antigens from the cytoplasm to the endoplasmic reticulum for association with MHC class I molecules. Also acts as a molecular scaffold for the final stage of MHC class I folding, namely the binding of peptide. Nascent MHC class I molecules associate with TAP via tapasin. Inhibited by the covalent attachment of herpes simplex virus ICP47 protein, which blocks the peptide-binding site of TAP. Inhibited by human cytomegalovirus US6 glycoprotein, which binds to the lumenal side of the TAP complex and inhibits peptide translocation by specifically blocking ATP-binding to TAP1 and prevents the conformational rearrangement of TAP induced by peptide binding. Inhibited by human adenovirus E3-19K glycoprotein, which binds the TAP complex and acts as a tapasin inhibitor, preventing MHC class I/TAP association. Expression of TAP1 is down-regulated by human Epstein-Barr virus vIL-10 protein, thereby affecting the transport of peptides into the endoplasmic reticulum and subsequent peptide loading by MHC class I molecules.
Defects in TAP1 are a cause of bare lymphocyte syndrome type 1 (BLS1) [MIM:604571]; also called HLA class I deficiency. BLS1 is a class I antigen deficiency that is not accompanied by particular pathologic manifestations during the first years of life. Systemic infections have not been described. Chronic bacterial infections, often beginning in the first decade of life, are restricted to the respiratory tract.
Belongs to the ABC transporter superfamily. ABCB family. MHC peptide exporter (TC 3.A.1.209) subfamily.
Contains 1 ABC transmembrane type-1 domain.
Contains 1 ABC transporter domain.
The peptide-binding site is shared between the cytoplasmic loops of TAP1 and TAP2.
Endoplasmic reticulum membrane. The transmembrane segments seem to form a pore in the membrane.
Target information above from: UniProt accessionQ03518
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
This product has been referenced in:
See 1 publication for this product
Publishing research using ab13516? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
